# Anti-PD-1 +/- RT for MSI-H Solid Tumors

> **NCT04001101** · PHASE2 · WITHDRAWN · sponsor: **University of Colorado, Denver**

## Conditions studied

- Microsatellite Instability High
- Mismatch Repair Deficiency
- Colorectal Cancer

## Interventions

- **COMBINATION_PRODUCT:** RT and Anti-PD-1
- **DRUG:** Anti-PD-1

## Key facts

- **NCT ID:** NCT04001101
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-10-10
- **Primary completion:** 2021-11-17
- **Final completion:** 2021-11-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI has decided to withdraw the study
- **Last updated:** 2021-11-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04001101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04001101, "Anti-PD-1 +/- RT for MSI-H Solid Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04001101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*